Ustekinumab Subcutaneous Injection and Zoledronic Acid Injection Concentrate
Determining the interaction of Ustekinumab Subcutaneous Injection and Zoledronic Acid Injection Concentrate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ustekinumab
Brand name: Stelara, Stelara PFS
Synonyms: Ustekinumab
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic acid, Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ustekinumab Subcutaneous Injection-Zoledronic acid Intravenous
- Ustekinumab Subcutaneous Injection-Zoledronic Acid IV
- Ustekinumab Subcutaneous Injection-Zolgensma
- Ustekinumab Subcutaneous Injection-Zolinza
- Ustekinumab Subcutaneous Injection-Zolmitriptan
- Ustekinumab Subcutaneous Injection-Zolmitriptan nasal
- Zoledronic Acid Injection Concentrate-Ustell
- Zoledronic Acid Injection Concentrate-UTA
- Zoledronic Acid Injection Concentrate-UTA Capsules
- Zoledronic Acid Injection Concentrate-UTAC tablets
- Zoledronic Acid Injection Concentrate-UTI Relief
- Zoledronic Acid Injection Concentrate-Utibron Neohaler